8-K: Creative Medical Shareholders Approve Warrant Exercise

Creative Medical Technology Holdings' stockholders approved the full exercise of warrants for 2.79 million common shares at a recent Special Meeting.

Summary

• A Special Meeting of Stockholders was held on December 26, 2025, by Creative Medical Technology Holdings, Inc.
• The purpose of the meeting was to consider and vote on a proposal to approve the exercise in full of warrants to purchase an aggregate of 2,790,340 shares of the company's common stock.
• These warrants were originally issued on October 29, 2025.
• Stockholders holding 1,037,465 shares of common stock, representing 36.4% of the outstanding shares, constituted a quorum at the meeting.
• The proposal was approved with 618,178 votes For, 183,985 Against, and 235,381 Abstain.
• In accordance with Nasdaq Listing Rules, 220,500 votes 'For' cast by holders of the Warrants were reclassified as 'Abstain' votes.

Sentiment

Score: 6

Explanation: The approval of the warrant exercise is a positive for the company's financial flexibility and ability to raise capital, but the resulting share dilution is a negative for existing shareholders, leading to a moderately positive overall sentiment for the company's operational stability.

Positives

• The approval of the warrant exercise allows the company to proceed with a planned capital event, potentially strengthening its financial position.
• The successful vote indicates shareholder support for the company's strategic financial decisions.

Negatives

• The exercise of 2,790,340 warrants will result in dilution for existing shareholders as more common stock enters circulation.

Risks

• Shareholder dilution due to the issuance of 2,790,340 new shares upon warrant exercise.

Future Outlook

The approval of the warrant exercise indicates the company's intent to proceed with the issuance of additional common stock, which will impact the capital structure.

Corporate Governance

Stakeholder Impact

• Shareholders: Will experience dilution due to the issuance of new shares from warrant exercise.
• Warrant Holders: Will be able to exercise their warrants in full, converting them into common stock.

Next Steps

• The company will proceed with the full exercise of the 2,790,340 warrants, leading to the issuance of additional common stock.

Key Dates

Keywords

Creative Medical Technology Holdings, CELZ, Warrant Exercise, Stockholder Meeting, Corporate Governance, SEC Filing, Capital Raise, Dilution, Nasdaq